International Clinical Trial: Study on the Clinical Characteristics, Genetic and Hereditary Features of Erythropoietic Protoporphyria (EPP) in the Chinese Population and the Efficacy and Safety of Red Blood Cell Exchange Transfusion for EPP

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117357) titled 'Study on the Clinical Characteristics, Genetic and Hereditary Features of Erythropoietic Protoporphyria (EPP) in the Chinese Population and the Efficacy and Safety of Red Blood Cell Exchange Transfusion for EPP' on Jan. 22.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: No. 900 Hospital of the Joint Logistic Support Force, People's Liberation Army of China

Condition: Porphyria

Intervention: EPP patient:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-01

Target Sample Size: EPP patient:10;Healthy Control :10;

Countries of Recruitm...